The common adverse reactions of GLP-1R agonists include gastrointestinal reactions, mainly loss of appetite, nausea, vomiting, diarrhea, abdominal pain, etc., primarily mild or moderate
it also constitutes a relatively independent neuropeptidergic regulatory system within the central nervous system
The ultimate choice must be made in consultation with an expert physician who can interpret the latest data and integrate the drug into a broader program focused on precision metabolic medicine and longevity
Cardiometabolic Risk Factors: Greater improvements in cardiometabolic risk factors compared to those taking a placebo
Addressing hypertriglyceridemia before starting GLP-1 receptor agonist therapy by implementing a low-carbohydrate diet and triglyceride-lowering medications could be preventive, even though GLP-1 receptor agonists will lower triglyceride levels
Your visit is with a licensed Family Nurse Practitioner who takes the time to listen, examine, and explain
